MAOLATE Drug Patent Profile
✉ Email this page to a colleague
When do Maolate patents expire, and what generic alternatives are available?
Maolate is a drug marketed by Pamlab Llc and is included in one NDA.
The generic ingredient in MAOLATE is chlorphenesin carbamate. There are two drug master file entries for this compound. Additional details are available on the chlorphenesin carbamate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MAOLATE?
- What are the global sales for MAOLATE?
- What is Average Wholesale Price for MAOLATE?
Summary for MAOLATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 49 |
| Patent Applications: | 736 |
| DailyMed Link: | MAOLATE at DailyMed |
US Patents and Regulatory Information for MAOLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pamlab Llc | MAOLATE | chlorphenesin carbamate | TABLET;ORAL | 014217-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
